Delivery Order SPE2DB22D1052-SPE2DB25FV0DA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of 1,000 tablets of Lisinopril 40 mg, with a ceiling value of $2,041.70 and an ultimate completion date of September 16, 2025. This competitively awarded, non-set-aside delivery order uses firm fixed price pricing and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of 1,000 tablets of Lisinopril-HCTZ 20-25 mg at a ceiling value of $1,344.35. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract has an ultimate completion date of August 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,131.97 to AmerisourceBergen Drug Corp for 1,000 tablets of Lisinopril 40 mg, with an ultimate completion date of September 9, 2025. This non-set-aside contract employs firm fixed price terms and represents a direct fulfillment order under AmerisourceBergen's existing contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of 1,000 tablets of Lisinopril-HCTZ 10-12.5 mg, a common antihypertensive medication used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $1,199.34, represents a non-competitive set-aside award and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 24, 2025. The...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,595.76 Firm Fixed Price Delivery Order contract is for the supply of 4,564,309,749 Lisinopril 40 mg tablets. The contract has an ultimate completion date of April 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at seventy-two thousand six hundred sixty-six dollars to Amerisourcebergen Drug Corporation for one thousand units of the pharmaceutical product Lisinopril 40 mg tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the specified pharmaceutical products to the location provided in Conshohocken, Pennsylvania by the designated period of performance between August 8-9, 2023. The Defense...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $252.92 to Amerisourcebergen Drug Corp for the provision of 1,000 tablets of the pharmaceutical Lisinopril 40 mg. As the prime contractor, Amerisourcebergen Drug Corp will deliver the products from its facility in Conshohocken, Pennsylvania under a start date of September 13, 2023 through completion by September 14, 2023. The Defense Logistics Agency routinely utilizes indefinite delivery/indefinite quantity...
- The Defense Logistics Agency Troop Support Medical awarded a $242,200 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 boxes of 40mg Lisinopril tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from June 26, 2023 through June 27, 2023. No major subcontractors or set aside designations were identified. This delivery order was issued under an existing Prime Vendor contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,000 units of the medication Lisinopril 40 mg tablets. The contract has a firm fixed price of $1,053.60 and a completion date of May 6, 2025. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999.00,...
- The Defense Logistics Agency awarded a $24,220 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 tablets of 40mg lisinopril. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 18-19, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing Government-Wide Acquisition Contract vehicle or set-aside...
- SPE2DB22D1052Indefinite Delivery Contract
- SPE2DB22D1052-SPE2DB25FV0DADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Lisinopril 40 mg tablets in quantities of 1,000 units, with a ceiling value of $1,085.32. This competitively awarded, firm fixed-price delivery order is set to complete by September 23, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a pharmaceutical distributor supporting federal medical procurement needs. This delivery order operates under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle valued through December 2026 that enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military and federal healthcare systems globally. The IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, serving customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's consistent performance on federal pharmaceutical contracts demonstrates its capability to meet stringent procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/22/25 |